Search clinical trials for: Paclitaxel/doxorubicin/cyclophosphamide
Total 8186 results
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnBreast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Avon FoundationTerminatedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Astex Pharmaceuticals, Inc.CompletedOvarian CancerCanada, United States, United Kingdom
-
Spanish Breast Cancer Research GroupSchering-PloughCompletedBreast CancerSpain
-
Cephalon, Inc.CompletedBreast CancerAustria, Belgium, France, Germany, Italy, Spain
-
Jules Bordet InstituteWithdrawn
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
National Cancer Institute (NCI)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
NHS Greater Glasgow and ClydeBoehringer Ingelheim; Cancer Research UK; European Organisation for Research... and other collaboratorsUnknownOvarian Clear Cell Carcinoma | Endometrial Clear Cell CarcinomaUnited Kingdom
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsCompletedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, Brazil, China, Germany, Hong Kong, Japan, Mexico, Romania, Switze... and more
-
OHSU Knight Cancer InstituteNovartis Pharmaceuticals; Oregon Health and Science UniversityCompletedStage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Locally Advanced Leiomyosarcoma | Unresectable Leiomyosarcoma | Myxofibrosarcoma | Metastatic Malignant Peripheral Nerve Sheath Tumor | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Unresectable... and other conditionsUnited States
-
German Breast GroupBristol-Myers Squibb; Pharmacia; AmgenCompleted
-
Hebei Medical University Fourth HospitalCompleted
-
Fundacao ChampalimaudNot yet recruitingTriple Negative Breast Cancer | Early Breast CancerPortugal
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruiting
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and...Terminated
-
Shanghai CP Guojian Pharmaceutical Co., Ltd.CompletedDiffuse Large B Cell LymphomaChina
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
University of GöttingenNordic Lymphoma Group; German High-Grade Non-Hodgkin's Lymphoma Study GroupUnknownExtranodal NK/T-cell Lymphoma | Peripheral T Cell Lymphoma, Unspecified | Angioimmunoblastic LymphadenopathyGermany
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
ETOP IBCSG Partners FoundationTerminatedBreast CancerItaly, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania
-
Nanfang Hospital of Southern Medical UniversityUnknownPeripheral T Cell LymphomaChina
-
Children's Cancer and Leukaemia GroupSociete Francaise Oncologie PediatriqueUnknown
-
Royal Marsden NHS Foundation TrustCompletedBreast CancerUnited Kingdom
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.RecruitingTNBC - Triple-Negative Breast CancerChina
-
Henan Cancer HospitalCompletedTriple Negative Breast CancerChina
-
Genelux CorporationGOG FoundationRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Platinum-refractory Ovarian Cancer | Primary Peritoneal Cancer | High-grade Serous Ovarian Cancer | Endometrioid Ovarian Cancer | Ovarian Clear Cell CarcinomaUnited States
-
University of CologneActive, not recruiting
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Western Regional Medical CenterTerminatedSarcoma | Breast Cancer | Small Cell Lung Cancer | Pancreatic Cancer | Advanced Cancer | OvarianUnited States
-
Barretos Cancer HospitalCompletedBRCA1 Hereditary Breast and Ovarian Cancer SyndromeBrazil
-
NSABP Foundation IncEisai Inc.CompletedBreast Cancer | HER2-negative Breast CancerUnited States, Canada
-
BeyondSpring Pharmaceuticals Inc.CompletedChemotherapy-induced NeutropeniaChina, Ukraine
-
National Cancer Center, KoreaCompleted
-
Memorial Sloan Kettering Cancer CenterPfizer; AmgenCompletedDose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityBreast Cancer | Adenocarcinoma of the BreastUnited States
-
Oslo University HospitalBristol-Myers Squibb; Helse Stavanger HF; Sorlandet Hospital HF; Cliniques universitaires... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive TumorNorway, Belgium
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
Prescient Therapeutics, Ltd.National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Breast AdenocarcinomaUnited States
-
Bristol-Myers SquibbCompletedBreast CancerChina, Russian Federation, United States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hong Kong, Ireland, Korea, Republic of, Mexico, Netherlands, Poland, Portuga... and more
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Medical Research CouncilCompletedBreast CancerUnited Kingdom, South Africa
-
ImmunoGen, Inc.Gynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Unknown
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
German High-Grade Non-Hodgkin's Lymphoma Study...CompletedLymphomaGermany, Israel, Italy
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia...Completed